









Markets
/
Stocks
/
nasdaq-nvst
/

Envista Holdings Corp

NVST

20.930USD

-0.100-0.48%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

3.49BMarket Cap

64.89P/E TTM



Envista Holdings Corp

20.930

-0.100-0.48%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

35 / 207

Overall Ranking

91 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 14 analysts

Hold

Current Rating

21.545

Target Price

+2.45%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Overvalued

The company’s latest PE is 64.94, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 199.63M shares, decreasing 14.01% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 16.92M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 7.64, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 682.10M, representing a year-over-year increase of 7.74%, while its net profit experienced a year-over-year increase of 102.29%.

Score

Industry at a Glance

Previous score

7.64

Change



Financials

7.33

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.74

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.52

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.43

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.18

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 6.28, which is higher than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is 65.25, which is -63.60% below the recent high of 23.75 and 104.04% above the recent low of -2.64.

Score

Industry at a Glance

Previous score

6.28

Change

1.21

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 35/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.86, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Envista Holdings Corp is 22.00, with a high of 25.00 and a low of 17.00.

Score

Industry at a Glance

Previous score

6.86

Change

Support & Resistance

No Data

Analyst Rating

Based on 14 analysts

Hold

Current Rating

21.545

Target Price

+2.45%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Envista Holdings Corp

NVST

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.77, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 21.82 and the support level at 20.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.77

Change

-0.09

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.085

Neutral

RSI(14)

50.628

Neutral

STOCH(KDJ)(9,3,3)

39.491

Sell

ATR(14)

0.626

Low Volatility

CCI(14)

-14.110

Neutral

Williams %R

44.586

Buy

TRIX(12,20)

0.087

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

21.034

Sell

MA10

21.052

Sell

MA20

21.064

Sell

MA50

20.601

Buy

MA100

19.518

Buy

MA200

19.152

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 120.11%, representing a quarter-over-quarter increase of 1.37%. The largest institutional shareholder is The Vanguard, holding a total of 16.92M shares, representing 10.18% of shares outstanding, with 1.71% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

17.02M

-1.27%

BlackRock Institutional Trust Company, N.A.

15.43M

+1.55%

Ariel Investments, LLC

Star Investors

12.14M

+0.71%

Atlanta Capital Management Company, L.L.C.

12.14M

+2.04%

Dimensional Fund Advisors, L.P.

8.39M

+24.03%

Franklin Mutual Advisers, LLC

7.67M

+11.93%

Harris Associates L.P.

Star Investors

8.68M

-7.86%

American Century Investment Management, Inc.

6.35M

-8.00%

Gates Capital Management, Inc.

5.16M

+10.00%

AllianceBernstein L.P.

4.55M

+1985.15%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 4.94, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.03. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.